US 5,166,065 · Granted 1992-11-24
In vitro propagation of embryonic stem cells
The present invention relates generally to the use of leukaemia inhibitory factor (LIF) in the maintenance and derivation of embryonic stem (ES) cells in culture. The ES cells are maintained and/or derived from animal embryos by culturing said cells or embryos in a culture medium containing an effective amount of LIF for a time and under conditions sufficient to maintain and/or derive said ES cells. The ES cells may be passaged in LIF and used to make chimaeric animals.
Patent details
- Publication number
- US 5,166,065
- Filing date
- 1989-08-03
- Grant date
- 1992-11-24
- Assignee
- Amrad Corporation Limited
- Inventor(s)
- WILLIAMS; ROBERT L., GOUGH; NICHOLAS M., HILTON; DOUGLAS J.
- CPC class
- A01K67/0275
Want to file your own patent?
Run your idea through our free scanner — we’ll show you which existing patents are conceptually closest, including this one if it’s a match.
Free patentability scanRelated patents in this cluster
- US 5,633,425: Transgenic non-human animals capable of producing heterologous antibodies
- US 5,545,807: Production of antibodies from transgenic animals
- US 5,661,016: Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
- US 6,075,181: Human antibodies derived from immunized xenomice